Report Detail

Request for Sample of this report

Pharma & Healthcare Global Mitomycin C Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3319765
    • |
  • 16 April, 2019
    • |
  • Global
    • |
  • 120 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Mitomycin C market, Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).

Scope of the Report:
In the last several years, Global market of Mitomycin C was experienced an upward trend rapidly, with an average growth rate of 4.76%. In 2016, Global Revenue of Mitomycin C is nearly 119.83 M USD; the actual production is about 17370 K Unit.

The global average price of Mitomycin C is in the increasing trend, from 6.30 USD/Unit in 2012 to 6.90 USD/Unit in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.

The classification of Mitomycin C includes 2 Mg, 10 Mg, 40 Mg, and others. The proportion of 2 Mg in 2016 is about 41.5%, and the proportion is in decreasing trend from 2012 to 2016.

Mitomycin C is widely used in Cancer Treatment, Ophthalmic Use, and other field. The most proportion of Mitomycin C is Cancer Treatment, and the proportion in 2016 is 69%. The trend of Cancer Treatment is decreasing.

Japan is the largest supplier of Mitomycin C, with a production market share nearly 26.5% in 2016. India is the second largest supplier of Mitomycin C Media, enjoying production market share nearly 25% in 2016.

North America is the largest consumption place, with a consumption market share nearly 36% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 32.6%.

Market competition is not intense. Kyowa-kirin, Intas Pharmaceuticals, Teva, Bristol-Myers Squibb, Aspen, Speciality European Pharma, etc. are the leaders of the industry.

The worldwide market for Mitomycin C is expected to grow at a CAGR of roughly -2.3% over the next five years, will reach 100 million US$ in 2024, from 120 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Mitomycin C in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Kyowa-kirin
Intas Pharmaceuticals
Teva
Bristol-Myers Squibb
Aspen
Speciality European Pharma
Alkem Laboratories
Varifarma
APOGEPHA

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
2 Mg
10 Mg
40 Mg
Other

Market Segment by Applications, can be divided into
Cancer Treatment
Ophthalmic Use
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mitomycin C product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Mitomycin C, with price, sales, revenue and global market share of Mitomycin C in 2017 and 2018.
Chapter 3, the Mitomycin C competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mitomycin C breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Mitomycin C market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Mitomycin C sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Mitomycin C Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 2 Mg
      • 1.2.2 10 Mg
      • 1.2.3 40 Mg
      • 1.2.4 Other
    • 1.3 Market Analysis by Applications
      • 1.3.1 Cancer Treatment
      • 1.3.2 Ophthalmic Use
      • 1.3.3 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Kyowa-kirin
      • 2.1.1 Business Overview
      • 2.1.2 Mitomycin C Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Kyowa-kirin Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Intas Pharmaceuticals
      • 2.2.1 Business Overview
      • 2.2.2 Mitomycin C Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Intas Pharmaceuticals Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Teva
      • 2.3.1 Business Overview
      • 2.3.2 Mitomycin C Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Teva Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Bristol-Myers Squibb
      • 2.4.1 Business Overview
      • 2.4.2 Mitomycin C Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Bristol-Myers Squibb Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Aspen
      • 2.5.1 Business Overview
      • 2.5.2 Mitomycin C Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Aspen Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Speciality European Pharma
      • 2.6.1 Business Overview
      • 2.6.2 Mitomycin C Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Speciality European Pharma Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Alkem Laboratories
      • 2.7.1 Business Overview
      • 2.7.2 Mitomycin C Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Alkem Laboratories Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Varifarma
      • 2.8.1 Business Overview
      • 2.8.2 Mitomycin C Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Varifarma Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 APOGEPHA
      • 2.9.1 Business Overview
      • 2.9.2 Mitomycin C Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 APOGEPHA Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Mitomycin C Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Mitomycin C Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Mitomycin C Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Mitomycin C Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Mitomycin C Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Mitomycin C Market Analysis by Regions

    • 4.1 Global Mitomycin C Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Mitomycin C Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Mitomycin C Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Mitomycin C Sales and Growth Rate (2014-2019)
    • 4.3 Europe Mitomycin C Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Mitomycin C Sales and Growth Rate (2014-2019)
    • 4.5 South America Mitomycin C Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Mitomycin C Sales and Growth Rate (2014-2019)

    5 North America Mitomycin C by Country

    • 5.1 North America Mitomycin C Sales, Revenue and Market Share by Country
      • 5.1.1 North America Mitomycin C Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Mitomycin C Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Mitomycin C Sales and Growth Rate (2014-2019)
    • 5.3 Canada Mitomycin C Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Mitomycin C Sales and Growth Rate (2014-2019)

    6 Europe Mitomycin C by Country

    • 6.1 Europe Mitomycin C Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Mitomycin C Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Mitomycin C Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Mitomycin C Sales and Growth Rate (2014-2019)
    • 6.3 UK Mitomycin C Sales and Growth Rate (2014-2019)
    • 6.4 France Mitomycin C Sales and Growth Rate (2014-2019)
    • 6.5 Russia Mitomycin C Sales and Growth Rate (2014-2019)
    • 6.6 Italy Mitomycin C Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Mitomycin C by Country

    • 7.1 Asia-Pacific Mitomycin C Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Mitomycin C Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Mitomycin C Revenue and Market Share by Country (2014-2019)
    • 7.2 China Mitomycin C Sales and Growth Rate (2014-2019)
    • 7.3 Japan Mitomycin C Sales and Growth Rate (2014-2019)
    • 7.4 Korea Mitomycin C Sales and Growth Rate (2014-2019)
    • 7.5 India Mitomycin C Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Mitomycin C Sales and Growth Rate (2014-2019)

    8 South America Mitomycin C by Country

    • 8.1 South America Mitomycin C Sales, Revenue and Market Share by Country
      • 8.1.1 South America Mitomycin C Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Mitomycin C Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Mitomycin C Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Mitomycin C Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Mitomycin C Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Mitomycin C by Countries

    • 9.1 Middle East and Africa Mitomycin C Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Mitomycin C Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Mitomycin C Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Mitomycin C Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Mitomycin C Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Mitomycin C Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Mitomycin C Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Mitomycin C Sales and Growth Rate (2014-2019)

    10 Global Mitomycin C Market Segment by Type

    • 10.1 Global Mitomycin C Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Mitomycin C Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Mitomycin C Revenue and Market Share by Type (2014-2019)
    • 10.2 2 Mg Sales Growth and Price
      • 10.2.1 Global 2 Mg Sales Growth (2014-2019)
      • 10.2.2 Global 2 Mg Price (2014-2019)
    • 10.3 10 Mg Sales Growth and Price
      • 10.3.1 Global 10 Mg Sales Growth (2014-2019)
      • 10.3.2 Global 10 Mg Price (2014-2019)
    • 10.4 40 Mg Sales Growth and Price
      • 10.4.1 Global 40 Mg Sales Growth (2014-2019)
      • 10.4.2 Global 40 Mg Price (2014-2019)
    • 10.5 Other Sales Growth and Price
      • 10.5.1 Global Other Sales Growth (2014-2019)
      • 10.5.2 Global Other Price (2014-2019)

    11 Global Mitomycin C Market Segment by Application

    • 11.1 Global Mitomycin C Sales Market Share by Application (2014-2019)
    • 11.2 Cancer Treatment Sales Growth (2014-2019)
    • 11.3 Ophthalmic Use Sales Growth (2014-2019)
    • 11.4 Others Sales Growth (2014-2019)

    12 Mitomycin C Market Forecast (2019-2024)

    • 12.1 Global Mitomycin C Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Mitomycin C Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Mitomycin C Market Forecast (2019-2024)
      • 12.2.2 Europe Mitomycin C Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Mitomycin C Market Forecast (2019-2024)
      • 12.2.4 South America Mitomycin C Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Mitomycin C Market Forecast (2019-2024)
    • 12.3 Mitomycin C Market Forecast by Type (2019-2024)
      • 12.3.1 Global Mitomycin C Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Mitomycin C Market Share Forecast by Type (2019-2024)
    • 12.4 Mitomycin C Market Forecast by Application (2019-2024)
      • 12.4.1 Global Mitomycin C Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Mitomycin C Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Mitomycin C . Industry analysis & Market Report on Mitomycin C is a syndicated market report, published as Global Mitomycin C Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Mitomycin C market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,745.72
      		4,118.58
      		5,491.44
      		3,201.60
      		4,802.40
      		6,403.20
      		539,991.60
      		809,987.40
      		1,079,983.20
      		290,580.00
      		435,870.00
      		581,160.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo